CTI Life Sciences announced today the first closing of its second venture capital fund ("CTI II"), with C$134 million of capital now available for investment. The new fund includes reaffirmed support from CTI's existing Québec institutional investors along with new investors Teralys Capital and BDC Capital via the Government of Canada's Venture Capital Action Plan.
from The Medical News http://ift.tt/1CqQ7Ny
from The Medical News http://ift.tt/1CqQ7Ny
No comments:
Post a Comment